INNOVADERM
Innovaderm Receives Top Recognition in the CRO Leadership Awards
Innovaderm today announced it has been awarded the CRO Leadership Awards. This huge achievement testifies to the excellency and ever-growing presence in the CRO world.
Innovaderm is offering full-service clinical research services, while serving its partners in their journey to discover new dermatology therapies.
Being selected by sponsors as top award winner in the Capabilities category, Innovaderm proves once more being top of mind for drug developers when it comes to selecting a CRO for their phase 1 to 3 with sites in North America and Europe. Other categories where Innovaderm performed in the top are: Expertise, Compatibility, Quality and Reliability.
"These award winners have proven themselves to be the top service providers in each category, said Ed Miseta, chief editor for Clinical Leader. "I congratulate all of them for work ethic they exhibit in consistently meeting the needs of their drug development clients."
The CRO Leadership Awards honours clinical research organizations that meet and exceed customer expectations. For 2021, Clinical Leader and Life Science Leader have once again teamed up with Industry Standard Research (ISR) to determine the winners. Recipients of the awards are vetted against more than 60 CROs and the participants are assessed by sponsor decision makers who have used clinical research services within the past 18 months.
Dr. Robert Bissonnette, Founder and CEO of Innovaderm, commented: “We are very pleased to receive this recognition. It is a tremendous honour to see our work acknowledged by Biotech and Pharma sponsors. At Innovaderm, we pride ourselves in offering niche expertise and quality services and these awards demonstrate that we are able to deliver.”
About Innovaderm
Innovaderm is a full-service contract research organization (CRO) offering support in the management of Phase 1 to 3 trials worldwide. Innovaderm partners with the drug industry to support single and multicenter clinical research & development. For the past 20 years, our team has supported sponsors with their medical, scientific and clinical execution in dermatology trials. To learn more about Innovaderm, please visit us on our website , LinkedIn , or Twitter .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210706005089/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NASPERS30.7.2021 19:02:58 CEST | Press release
Prosus FAQ's Regarding the Voluntary Share Exchange Offer to the Holders of Naspers N Ordinary Shares
PROSUS30.7.2021 19:01:08 CEST | Press release
Prosus FAQ's Regarding the Voluntary Share Exchange Offer to the Holders of Naspers N Ordinary Shares
I’MBESIDEYOU30.7.2021 16:27:11 CEST | Press release
I’mbesideyou Inc. Launched “UNION OF EMOTIONS” Service Using AI to Visualize Cheering Each Other Across National Borders
NY-GOLDMAN-SACHS30.7.2021 14:25:14 CEST | Press release
Palace Bidco Oy (“WSIP Bidco”) Has Received Necessary Regulatory Approval Concerning the Recommended Cash Offer to the Shareholders of Adapteo Plc (“Adapteo”)
ITRS-GROUP30.7.2021 10:02:14 CEST | Press release
ITRS Group Continues Expansion With the Acquisition Of Opsview
TAIPEI-EXCHANGE30.7.2021 10:02:14 CEST | Press release
Taipei Exchange Launches Pioneer Stock Board to Support Innovative Enterprises
MA-SCHNEIDER-ELECTRIC30.7.2021 08:34:12 CEST | Press release
Schneider Electric Moves Forward With Its Sustainability Impact Targets, Mobilizing Support From Employees, Partners and Customers
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom